Digital Patient recruitment and pre-screening methodsfor atopic dermatitis

whitePaper | December 10, 2022

Healthcare’s workforce is in crisis. Waves of employee departures amid a once-in-a-century public health crisis have left hospitals all over the nation scrambling to fill critical roles across the enterprise.

whitePaper | May 2, 2022

Medical device cybersecurity is getting more attention than ever before. There are several reasons for this. New regulations, the SBOM initiative, and President's Biden’s executive order and subsequent request from Congress for a 14% increase in budget for supply chain and cybersecurity

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.

whitePaper | October 12, 2022

The configurability options of a deep digital health white label span from how you accept patients, to how you coordinate care, to how you treat specific medical conditions. This is difficult to achieve with a static solution with fixed capabilities.

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.